Mitral Valve Disease Market Updates 2024 : Rise in Prevalence of Mitral Valve Diseases is Pushing to USD 5.7 Billion Market Revenue by 2031, Report

According to the report published by allied Market Research, the global mitral valve disease market garnered $2.5 billion in 2021, and is estimated to generate $5.7 billion by 2031, manifesting a CAGR of 8.8% from 2022 to 2031.

What is Driving Mitral Valve Disease Market ?

he increasing prevalence of mitral valve diseases and the development of advanced technologies for their treatment are key trends driving the growth of the mitral valve disease market.

Additionally, the rising demand for minimally invasive surgeries to treat malfunctioning mitral valves significantly fuels market growth. This is largely because traditional open-heart surgery for mitral valve replacement is highly invasive, involves a lengthy recovery period, and carries substantial risk of complications. Consequently, the preference for minimally invasive procedures, which offer shorter recovery times and fewer risks, is expanding the mitral valve disease market.

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/A74388

Based on end user, the hospitals segment dominated the global mitral valve disease market in 2021, accounting for nearly three-fifths of the total market share. This segment is anticipated to maintain its leading position throughout the forecast period, with an expected compound annual growth rate (CAGR) of 9.2% from 2022 to 2031.

Regionally, North America held the largest market share in 2021, contributing to over two-fifths of the global mitral valve disease market. This region is projected to continue its revenue dominance through 2031. Additionally, the Asia-Pacific region is expected to exhibit the fastest CAGR, at 9.8%, during the forecast period.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/A74388

Recent Approvals in Mitral Valve Disease Market

• In January 2020, Abbott received the CE Mark approval of Abbott’s Tendyne Transcatheter Mitral Valve Implantation (TMVI) system used in the treatment of mitral regurgitation (MR) in patients who require a heart valve replacement and is now approved for use in Europe.
• In September 2021, Abbott received the U.S. Food and Drug Administration (FDA) approval for Epic Plus and Epic Plus Supra Stented Tissue Valves. These new devices are based on Abbott’s Epic surgical valve platform, which improve therapy options for people with aortic or mitral valve disease.

Divestment in Mitral Valve Disease Market 

• In June 2021, Corcym announced the launch of its operations globally, which is formed from the acquisition of the LivaNova Plc. heart valve business by Gyrus Capital. The new, independent, medical device company will be dedicated towards providing patients and heart surgeons with the best solutions to fight structural heart disease.

Investment in the Mitral Valve Disease Market 

• In March 2019, Edwards Lifesciences Corporation has announced two strategic transactions involving companies with structural heart disease technologies. The transaction involves a $35 million investment in an exclusive right to acquire Corvia Medical, Inc. and the acquisition of certain assets of Mitralign, Inc, a company that specializes in developing devices for the treatment of mitral valve regurgitation.

New Product Development in Mitral Valve Disease Market

• In November 2021, Medtronic plc. presented early data for Intrepid transcatheter mitral valve replacement (TMVR) system in patients with severe, symptomatic mitral valve regurgitation (MR) utilizing the transfemoral access route. The data from first 5 patients enrolled in an Early Feasibility Study of the Intrepid Transfemoral System showed 100% survival and no stroke and none or trace MR in all implanted patients at 30 days.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mitral valve disease market analysis from 2021 to 2031 to identify the prevailing mitral valve disease market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the mitral valve disease market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global mitral valve disease market trends, key players, market segments, application areas, and market growth strategies.

Key findings of the study
• On the basis of treatment type, the mitral valve repair segment was highest contributor to the market in 2021; however, the mitral valve replacement segment is anticipated to grow at the fastest rate during the forecast period.
• Depending on indication, the mitral valve regurgitation segment dominated the mitral valve disease industry in 2021; however, the mitral valve stenosis segment is anticipated to grow at the highest CAGR in the coming future.
• By end user, the hospitals segment led the mitral valve disease industry in 2021 and is anticipated to grow at the highest CAGR.
• Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Leading market players of the global mitral valve disease market analyzed in the research,

• Zydus Lifesciences Limited
• Valcare Medical
• Novartis AG
• Medtronic plc
• Braile Biomedica
• Labcor Laboratorios Ltda
• Edwards Lifesciences Corporation
• Bayer AG
• Affluent Medical
• Corcym UK Limited
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• ShockWave Medical Inc.
• Artivion Inc.
• Abbott Laboratories.

Other Trending Reports in Healthcare Industry-

Behavioral Health Market https://www.alliedmarketresearch.com/behavioral-health-market-A17079

Medical Exoskeleton Market https://www.alliedmarketresearch.com/medical-exoskeleton-market-A11183

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter